Sign In
test

Glenn Shepard

Suvretta Capital Management, Llc

Assets Managed
$3.915B
Holdings
89
Last Quarter
2026 - Q1
Filed Date
7d ago
Growth Rate
-19.8%(2Q avg: 2.58%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Suvretta Capital Management, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 89 positions.

Assets under management

The assets under management (AUM) of Suvretta Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 3.915B in assets, with a quarterly growth rate of -19.8% and a 2-quarter average growth rate of 2.58%. The portfolio is managed by Glenn Shepard, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
ARQT
Arcutis Biotherapeutics Inc
Recent Activity
Increased 3.04%
7.42%
$290.424M
12.327M shares@ $23.56 avg price
MANE
Veradermics Inc
Recent Activity
New Position
6.73%
$263.27M
4.169M shares@ $63.16 avg price
SPY
Spdr S&p 500 Etf Trust
Recent Activity
Decreased -56.25%
5.82%
$227.619M↓ Put
350,000 shares@ $650.34 avg price
PVLA
Palvella Therapeutics Inc
Recent Activity
Increased 29.26%
3.68%
$143.783M
1.153M shares@ $124.65 avg price
APLS
Apellis Pharmaceuticals Inc
Recent Activity
Decreased -15%
3.62%
$141.548M
3.518M shares@ $40.23 avg price
LEGN
Legend Biotech Corp-adr
Recent Activity
Increased 14.72%
3.51%
$137.141M
7.581M shares@ $18.1 avg price
BNTC
Benitec Biopharma Inc
Recent Activity
3.15%
$122.99M
11.548M shares@ $10.65 avg price
CAPR
Capricor Therapeutics Inc
Recent Activity
Increased 113.86%
2.97%
$116.085M
3.819M shares@ $30.4 avg price
IMTX
Immatics Nv
Recent Activity
2.82%
$110.111M
11.19M shares@ $9.84 avg price
RCUS
Arcus Biosciences Inc
Recent Activity
Decreased -3.04%
2.78%
$108.669M
5.031M shares@ $21.61 avg price

1-10 of 89